Skip to Content

China Pharma Holding Inc CPHI

Morningstar Rating
$0.07 −0.01 (11.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CPHI is trading at a 60% discount.
Price
$0.07
Fair Value
$7.73
Uncertainty
Extreme
1-Star Price
$2.13
5-Star Price
$9.37
Economic Moat
Sfjp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CPHI is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.08
Day Range
$0.070.08
52-Week Range
$0.070.80
Bid/Ask
$0.07 / $0.08
Market Cap
$3.82 Mil
Volume/Avg
2.4 Mil / 3.9 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.09
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
244

Valuation

Metric
CPHI
Price/Earnings (Normalized)
Price/Book Value
0.34
Price/Sales
0.09
Price/Cash Flow
Price/Earnings
CPHI

Financial Strength

Metric
CPHI
Quick Ratio
0.25
Current Ratio
0.82
Interest Coverage
−7.21
Quick Ratio
CPHI

Profitability

Metric
CPHI
Return on Assets (Normalized)
−19.08%
Return on Equity (Normalized)
−70.65%
Return on Invested Capital (Normalized)
−22.00%
Return on Assets
CPHI
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ANpbd$91.1 Bil
MKKGY
Merck KGaA ADRDpmxjk$74.5 Bil
HLN
Haleon PLC ADRHjc$37.7 Bil
VTRS
Viatris IncRsmr$15.9 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRCwc$15.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRVpy$13.0 Bil
CTLT
Catalent IncYdgbvg$10.5 Bil
PRGO
Perrigo Co PLCQbm$3.7 Bil
CURLF
Curaleaf Holdings IncJdzyk$3.7 Bil
PBH
Prestige Consumer Healthcare IncQvhpmr$3.5 Bil

Sponsor Center